| |
Period of study
|
Number of patients
|
Overall survival (%)
|
Cancer specific survival (%)
|
Disease free interval (%)
|
|---|
|
Haigh et al. (SEER) [16]
|
1988–1993
|
172
|
73
| | |
|
Lopez-Penabad et al. [14]
|
1944–1995
|
89
|
55
|
64
| |
|
Bhattacharyya et al. (SEER) [4]
|
1973–1998
|
555
|
71.1
| | |
|
Stojadinovic et al. [7]
|
1940–2000
|
56
| |
73
|
61
|
|
Kushchayeva et al. [11]
|
1976–2002
|
33
| |
49
|
40.5
|
|
Mills et al. [8]
|
1946–2003
|
62
| |
64
|
43
|
|
Jillard et al. (National Cancer Database) [17]
|
1998–2006
|
1909
|
70.7
| | |
|
Nagar et al. (SEER-9) [1]
|
1975–2009
|
1416
|
77.1
| | |
|
Goffredo et al. (SEER) [2]
|
1988–2009
|
3311
| |
91
| |
|
Sugino et al. [10]
|
1989–2010
|
73
| |
93.1
| |
|
Petric et al. [6]
|
1972–2011
|
108
| |
88
|
68
|
|
Our study
|
1995–2014
|
239
|
77.2
|
92.5
|
86.2
|
-
SEER surveillance, epidemiology, and end results
